Morocco’s House of Councillors commission has approved bill 27.26, aiming to strengthen the regulation of medicines and health products. The legislation enhances the authority of the Moroccan Agency for Medicines and Health Products, granting it increased oversight capabilities. A key focus of the bill is stricter regulation of dietary supplements, particularly those with compositions, dosages, or effects requiring a medical prescription. This move intends to ensure greater public health safety and control over potentially harmful or mislabeled products. The bill’s passage through the commission represents a significant step towards modernizing pharmaceutical and health product governance in Morocco. Further legislative stages are expected before the bill becomes law. The initiative reflects a broader effort to align Moroccan health standards with international best practices.